Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
about
Genetic manipulation in pigsImmune modulation in xenotransplantationCardiac xenotransplantation: progress and challengesImmunobiological barriers to xenotransplantationSystemic inflammation in xenograft recipients (SIXR): A new paradigm in pig-to-primate xenotransplantation?Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation.Overcoming the barriers to xenotransplantation: prospects for the futureCurrent status of xenotransplantation and prospects for clinical applicationProlonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model.Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionReduced binding of human antibodies to cells from GGTA1/CMAH KO pigs.The role of genetically engineered pigs in xenotransplantation research.Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograftProgress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literatureDevelopment of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cellsSystemic inflammation in xenograft recipients precedes activation of coagulationThe utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation.Which anti-platelet therapies might be beneficial in xenotransplantation?Xenotransplantation as a model of integrated, multidisciplinary researchAchieving tolerance in pig-to-primate xenotransplantation: reality or fantasy.Update: cardiac xenotransplantation.Complement activation and coagulation in xenotransplantation.Xenograft tolerance and immune function of human T cells developing in pig thymus xenografts.Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates.T-cell-mediated immunological barriers to xenotransplantationThe role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.The pathobiology of pig-to-primate xenotransplantation: a historical review.Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice.Changes in cardiac gene expression after pig-to-primate orthotopic xenotransplantation.Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?
P2860
Q24654314-CF620206-55AD-4CFA-8721-50590ACF4861Q26826905-D364942A-054B-4D3C-A36F-CF98C3E1C7F0Q27024045-8D9D3395-B15C-4ADC-BFC2-AB2945CCB3CFQ28081993-73452533-E7FD-425E-9BB3-87646103DB84Q28084493-DAA40054-F2DF-40DA-B1E3-E7AC61925075Q33401474-5F64C984-26C6-4170-8511-2E7921611BE4Q33801035-C57FBB93-6B30-428A-9260-56A72D9B123CQ33835678-524259DD-3636-40D4-9481-C0B37989DA79Q33999068-2941436B-F70D-4154-B4AA-7CD20CA75575Q34018912-A5DEF909-644E-44CE-BD79-46D81B7311ABQ34041201-D0541837-A2AE-4461-9140-E831D7781062Q34044894-011A37D2-8409-490E-9713-BD7696CD2A4FQ34046578-536EEFC9-68F6-46F9-840A-197D8B6105C4Q34250530-08B14A5A-441F-41A8-B12B-BA39EC0CA1FDQ34674677-BCA5B214-8520-407F-84F1-4B37DF5E7DAFQ35085219-48D258AA-8407-4FC6-8A64-93F9C9A59C38Q36183720-02269B3F-6559-4C7C-BD8B-FA841B28E0DCQ37069089-172EC53D-C15E-4FE1-9227-E66DD5068F72Q37137178-36FA0EE4-DFC3-44F0-80AF-A4D55C311F27Q37342291-19EA0520-AD54-4A26-91E8-CF9D15FC0DD0Q37342534-88EF80B6-464C-48EC-8787-5DB0ECF778A6Q37372498-194C7009-6FC8-49B6-980F-0DA0519D8878Q37698522-E5AE0F5D-B822-402E-BC06-E0E329682954Q37854406-AAD1BE96-5A69-4549-B633-7E5BFF0953EEQ37987617-1D93D74F-9945-4970-9C5B-CA4884FB52A9Q38191251-87DDC056-7A8B-46CA-BAC7-6B440D239E8CQ38712532-4C4D98DD-817B-4492-9056-B9017EECE69EQ42069374-5508C000-8949-4A64-A3CE-92F4498D6C01Q42691617-40088713-59A7-49C6-9AF9-DF06AADD5A2CQ43414006-CFCC7B11-25B7-4A03-B48B-FAB011560D0CQ47136558-4E87BA64-8B41-4AB4-87A4-1BD88A66A4F9
P2860
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@ast
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@en
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@nl
type
label
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@ast
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@en
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@nl
prefLabel
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@ast
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@en
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@nl
P2093
P921
P3181
P1433
P1476
Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival
@en
P2093
Christopher G A McGregor
Guerard W Byrne
Henry D Tazelaar
John S Logan
Randall C Walker
Sumeet S Teotia
Vinay P Rao
William R Davies
P304
P3181
P356
10.1097/01.TP.0000251387.40499.0F
P407
P50
P577
2006-12-01T00:00:00Z